Clinical Trial Update: Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of paclitaxel, topotecan, and cisplatin in patients with advanced, persistent, or recurrent cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED